Emir Sandhu

Emir Sandhu, MD, MBA, joined Sandbox in 2019 and is a Partner of Sandbox Clinical Ventures and the Blue Venture Funds. He currently serves on the board of directors of Limber Health, Onc.AI, and Ultromics, and is a board observer of Exai Bio, Octave Bioscience, Somatus, and SonarMD. He also supports or has supported the Blue Venture Fund's investments in Owl Health, CirrusMD, Thrive Earlier Detection, PicassoMD, and HeartFlow. Dr. Sandhu is a physician and completed his radiology residency at Stanford University and Memorial Sloan Kettering Cancer Center. He served as adjunct faculty in Diagnostic Radiology at Stanford University School of Medicine and was selected for the 2020 faculty teaching award by Stanford residents and students.

Prior to Sandbox, Dr. Sandhu consulted on medical innovation initiatives at Google and co-founded OpenBiome, a nonprofit organization in Somerville, Massachusetts, which supports research on the human microbiome and has treated patients suffering from C. difficile infection. Dr. Sandhu holds an MD from Harvard Medical School, an MBA from Harvard Business School and a BA in Economics from the University of North Carolina as a Morehead-Cain Scholar.